Association Between the G20210A Polymorphism of Prothrombin Gene and Myocardial Infarction in Tunisian Population

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Biochemical Genetics

• Publication date

  2016-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10528-016-9744-yPMID 27306359
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endothelial Nitric Oxide Synthase T-786C Mutation, Prothrombin Gene Mutation (G-20210-A) and Protein S Deficiency Could Lead to Myocardial Infarction in a Very Young Male Adult

  2016cited by this paper
• Prothrombin G20210A Mutation Is Associated With Young-Onset Stroke: The Genetics of Early-Onset Stroke Study and Meta-Analysis

  2014cited by this paper
• Genetic risk factors of atherothrombosis.

  2014cited by this paper
• Lack of association between factor V Leiden and prothrombin G20210A polymorphisms in Tunisian subjects with a history of myocardial infarction.

  2013cited by this paper
• Prevalence of coagulation factor II G20210A and factor V G1691A Leiden polymorphisms in Chechans, a genetically isolated population in Jordan

  2012cited by this paper
• Arterial thrombus formation in cardiovascular disease

  2011cited by this paper
• Analysis of polymorphisms Leiden Factor V G1691A and prothrombin G20210A as risk factors for acute myocardial infarction

  2011cited by this paper
• Mediterranean Journal of Hematology and Infectious Diseases Epidemiology of Prothrombin G20210a High Prevalence of Prothrombin G20210a Mutation Was Reported in Caucasian Populations, but the Prevalence Was Almost absent in Non Europe and the Mediterranean Region. This Review Article Discusses Prothr

  2011cited by this paper
• Factor V Leiden and Prothrombin G20210A Mutations Among Healthy Indians in Malaysia

  2010cited by this paper
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• Cardiovascular disease and heritability of the prothrombotic state.

  2009cited by this paper
• Prothombin gene G20210A mutation is not a risk factor for ischemic stroke in a South Indian Hyderabadi Population.

  2009cited by this paper
• Pathogenesis of atherosclerosis.

  2006cited by this paper
• Distinct association of factor V‐Leiden and prothrombin G20210A mutations with deep venous thrombosis in Tunisia and Lebanon

  2006cited by this paper
• Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls.

  2006cited by this paper
• Prevalence of antiphospholipid antibodies, factor V G1691A (Leiden) and prothrombin G20210A mutations in early and late recurrent pregnancy loss.

  2005cited by this paper
• G20210A is a functional mutation in the prothrombin gene; effect on protein levels and 3′‐end formation

  2004cited by this paper
• Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies.

  2003cited by this paper
• G20210A Prothrombin gene polymorphism and coronary ischaemic syndromes: a phenotype-specific meta-analysis of 12 034 subjects

  2003cited by this paper
• Frequent occurrence of anticardiolipin antibodies, Factor V Leiden mutation, and perturbed endothelial function in chronic myeloproliferative disorders

  2002cited by this paper
• Prevalence of Two Thrombophilia Predisposing Mutations: Factor V G1691A (R506Q; Leiden) and Prothrombin G20210A, among Healthy Lebanese

  2002cited by this paper
• Arterial wall thickness and the risk of recurrent ischemic events in carriers of the prothrombin G20210A mutation with clinical manifestations of atherosclerosis.

  2002cited by this paper
• Increased prevalence of the G20210A prothrombin gene variant in acute coronary syndromes without metabolic or acquired risk factors or with limited extent of disease.

  2002cited by this paper
• Increased efficiency of mRNA 3′ end formation: a new genetic mechanism contributing to hereditary thrombophilia

  2001cited by this paper
• G20210A Prothrombin Gene Polymorphism and Prothrombin Activity in Subjects With or Without Angiographically Documented Coronary Artery Disease

  2001cited by this paper
• Linkage analysis demonstrates that the prothrombin G20210A mutation jointly influences plasma prothrombin levels and risk of thrombosis.

  2000cited by this paper
• [Prevalence of G20210A prothrombin gene mutation in Poland].

  2000cited by this paper
• Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population

  2000cited by this paper
• Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

  2000cited by this paper
• Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

  2000cited by this paper
• Coagulation factors II, V, VII, and X, prothrombin gene 20210G-->A transition, and factor V Leiden in coronary artery disease: high factor V clotting activity is an independent risk factor for myocardial infarction.

  1999cited by this paper
• Prevalence of Prothrombin G20210A, Factor V G1691A (Leiden), and Methylenetetrahydrofolate Reductase (MTHFR) C677T in Seven Different Populations Determined by Multiplex Allele-specific PCR

  1999cited by this paper
• Prevalence of the Prothrombin Gene 20210A Mutation in Thrombophilic and Healthy Algerian Subjects

  1999cited by this paper
• The 20210 G → A mutation in the 3′‐untranslated region of the prothrombin gene and the risk for arterial thrombotic disease

  1999cited by this paper
• The Prothrombin 20210A Allele and Its Association with Myocardial Infarction

  1999cited by this paper
• G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men.

  1999cited by this paper
• Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young males.

  1999cited by this paper
• Geographic Distribution of the 20210 G to A Prothrombin Variant

  1998cited by this paper
• No Association between the 20210 G/A Prothrombin Gene Mutation and Premature Coronary Artery Disease

  1998cited by this paper
• Risk of Myocardial Infarction Associated With Factor V Leiden or Prothrombin Interaction of Coagulation Defects and Cardiovascular Risk Factors : Increased

  1998cited by this paper
• Frequencies of prothrombin 20210 G-->A mutation may be different among races--studies on Japanese populations with various forms of thrombotic disorders and healthy subjects.

  1998cited by this paper
• Prevalence of the Prothrombin Gene Variant (nt20210A) in Venous Thrombosis and Arterial Disease

  1997cited by this paper
• Physical Status: The Use and Interpretation of Anthropometry. Report of a WHO Expert Committee

  1996cited by this paper
• A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.

  1996influential reference
• Increased Activation of the Haemostatic System in Men at High Risk of Fatal Coronary Heart Disease

  1996cited by this paper
• Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee.

  1995cited by this paper
• A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies.

  1991cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper

• ATR1 A1166C (rs5186), FII G20210A (rs1799963), FV G1691A (rs6025), FXIII 97G > T (rs11466016) and MTHFR A1298C (rs1801131) polymorphisms and the risk of ST-elevation myocardial infarction in young Mexican individuals

  2024cites this paper
• Factor V Leiden but not the factor II 20210G>A mutation is a risk factor for premature coronary artery disease: a case-control study in Iran

  2023cites this paper
• Genetic variations associated with coronary artery disease and myocardial infarction in the Arab world: a systematic review and meta-analysis

  2020influential citation
• Acute scrotum caused by an extraspermatic venous thrombosis associated with G20210A prothrombin gene mutation in a pediatric patient: A case report

  2019cites this paper
• Mitochondrial Genome Mutations Associated with Myocardial Infarction

  2018cites this paper